Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Raduner

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Receptor and Signal Transduction Research|November 23, 2006
New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptorsJürg Gertsch, Stefan Raduner, Karl-Heinz Altmann
Journal of Natural Products|May 15, 2007
Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amidesStefan Raduner, William Bisson, Ruben Abagyan, et al.
International Immunopharmacology|March 24, 2009
Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extractsAndrea Chicca, Stefan Raduner, Federica Pellati, et al.
Biochemical Pharmacology|March 9, 2010
Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skinMarco Leonti, Laura Casu, Stefan Raduner, et al.
Organic & Biomolecular Chemistry|December 14, 2006
Stereoselective synthesis, natural occurrence and CB(2) receptor binding affinities of alkylamides from herbal medicines such as Echinacea spN Matovic, A Matthias, Jürg Gertsch, et al.
The Journal of Biological Chemistry|March 21, 2006
Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effectsStefan Raduner, Adriana Majewska, Jian-Zhong Chen, et al.
Chemistry & Biology|August 27, 2011
Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonistsWolfgang Schuehly, Juan Manuel Viveros Paredes, Jonas Kleyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2008
Beta-caryophyllene is a dietary cannabinoidJürg Gertsch, Marco Leonti, Stefan Raduner, et al.
Planta Medica|December 20, 2008
In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolensJudith M Rollinger, Daniela Schuster, Birgit Danzl, et al.
Journal of Medicinal Chemistry|January 16, 2009
Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflowPatrick Markt, Clemens Feldmann, Judith Maria Rollinger, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Receptor and Signal Transduction Research|November 23, 2006
New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptorsJürg Gertsch, Stefan Raduner, Karl-Heinz Altmann
Journal of Natural Products|May 15, 2007
Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amidesStefan Raduner, William Bisson, Ruben Abagyan, et al.
International Immunopharmacology|March 24, 2009
Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extractsAndrea Chicca, Stefan Raduner, Federica Pellati, et al.
Biochemical Pharmacology|March 9, 2010
Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skinMarco Leonti, Laura Casu, Stefan Raduner, et al.
Organic & Biomolecular Chemistry|December 14, 2006
Stereoselective synthesis, natural occurrence and CB(2) receptor binding affinities of alkylamides from herbal medicines such as Echinacea spN Matovic, A Matthias, Jürg Gertsch, et al.
The Journal of Biological Chemistry|March 21, 2006
Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effectsStefan Raduner, Adriana Majewska, Jian-Zhong Chen, et al.
Chemistry & Biology|August 27, 2011
Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonistsWolfgang Schuehly, Juan Manuel Viveros Paredes, Jonas Kleyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2008
Beta-caryophyllene is a dietary cannabinoidJürg Gertsch, Marco Leonti, Stefan Raduner, et al.
Planta Medica|December 20, 2008
In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolensJudith M Rollinger, Daniela Schuster, Birgit Danzl, et al.
Journal of Medicinal Chemistry|January 16, 2009
Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflowPatrick Markt, Clemens Feldmann, Judith Maria Rollinger, et al.
Pageof 1